L3VLUP
ProSign in

ANAB · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ANABJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ANAB
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterANABJNJ
Q3 20201 holders, $948k30 holders, $26.2bn
Q4 20202 holders, $17m32 holders, $26.6bn
Q1 20211 holders, $9.2m31 holders, $25.3bn
Q2 20211 holders, $14m37 holders, $25.6bn
Q3 20212 holders, $32m40 holders, $24.1bn
Q4 20213 holders, $31m33 holders, $25.2bn
Q1 20222 holders, $53m35 holders, $28.2bn
Q2 20222 holders, $36m33 holders, $26.9bn
Q3 20222 holders, $93m36 holders, $25.4bn
Q4 20222 holders, $86m35 holders, $27.6bn
Q1 20232 holders, $47m42 holders, $24.5bn
Q2 20232 holders, $51m38 holders, $25.0bn
Q3 20233 holders, $17m37 holders, $18.9bn
Q4 20234 holders, $45m31 holders, $19.0bn
Q1 20243 holders, $34m32 holders, $19.7bn
Q2 20241 holders, $6.3m35 holders, $20.4bn
Q3 20243 holders, $22m28 holders, $22.3bn
Q4 20241 holders, $6.4m37 holders, $20.4bn
Q1 20253 holders, $60m32 holders, $20.5bn
Q2 20253 holders, $67m31 holders, $18.4bn
Q3 20254 holders, $97m32 holders, $23.7bn
Q4 20254 holders, $137m29 holders, $27.8bn
Q1 20262 holders, $20m34 holders, $35.6bn
Q2 20261 holders, $48m33 holders, $39.1bn
ANAB

Anaptysbio Inc

Holders
3
Reported value
$34m
Buyers
2
Sellers
2

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
32
Reported value
$19.7bn
Buyers
16
Sellers
13

Breadth +3 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2024

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ANAB (1)

Point72 Asset Management LP

Only JNJ (30)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, and 5 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →